Race Oncology Limited RAC.AX Stock
Race Oncology Limited Price Chart
Race Oncology Limited RAC.AX Financial and Trading Overview
| Race Oncology Limited stock price | 1.49 AUD |
| Previous Close | 1.47 AUD |
| Open | 1.47 AUD |
| Bid | 1.43 AUD x 0 |
| Ask | 1.48 AUD x 0 |
| Day's Range | 1.43 - 1.5 AUD |
| 52 Week Range | 1.31 - 2.87 AUD |
| Volume | 150.96K AUD |
| Avg. Volume | 136.04K AUD |
| Market Cap | 240.53M AUD |
| Beta (5Y Monthly) | 1.596168 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RAC.AX Valuation Measures
| Enterprise Value | 199.3M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 174.81236 |
| Price/Book (mrq) | 7.722513 |
| Enterprise Value/Revenue | 144.847 |
| Enterprise Value/EBITDA | -18.751 |
Trading Information
Race Oncology Limited Stock Price History
| Beta (5Y Monthly) | 1.596168 |
| 52-Week Change | -3.60% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.87 AUD |
| 52 Week Low | 1.31 AUD |
| 50-Day Moving Average | 1.71 AUD |
| 200-Day Moving Average | 2 AUD |
RAC.AX Share Statistics
| Avg. Volume (3 month) | 136.04K AUD |
| Avg. Daily Volume (10-Days) | 123.93K AUD |
| Shares Outstanding | 163.07M |
| Float | 112.44M |
| Short Ratio | N/A |
| % Held by Insiders | 39.79% |
| % Held by Institutions | 4.39% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -792.90% |
| Gross Margin | -22.33% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.51% |
| Return on Equity (ttm) | -29.96% |
Income Statement
| Revenue (ttm) | 1.38M AUD |
| Revenue Per Share (ttm) | 0.009 AUD |
| Quarterly Revenue Growth (yoy) | 86.79% |
| Gross Profit (ttm) | -228537 AUD |
| EBITDA | -10628554 AUD |
| Net Income Avi to Common (ttm) | -10791857 AUD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 26.37M AUD |
| Total Cash Per Share (mrq) | 0.16 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 33.902 |
| Book Value Per Share (mrq) | 0.191 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9400518 AUD |
| Levered Free Cash Flow (ttm) | -5499000 AUD |
Profile of Race Oncology Limited
| Country | Australia |
| State | NSW |
| City | Sydney |
| Address | Gateway, 1 Macquarie Place |
| ZIP | 2000 |
| Phone | 61 2 8051 3043 |
| Website | https://www.raceoncology.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limited was incorporated in 2011 and is based in Sydney, Australia.
Q&A For Race Oncology Limited Stock
What is a current RAC.AX stock price?
Race Oncology Limited RAC.AX stock price today per share is 1.49 AUD.
How to purchase Race Oncology Limited stock?
You can buy RAC.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Race Oncology Limited?
The stock symbol or ticker of Race Oncology Limited is RAC.AX.
Which industry does the Race Oncology Limited company belong to?
The Race Oncology Limited industry is Biotechnology.
How many shares does Race Oncology Limited have in circulation?
The max supply of Race Oncology Limited shares is 165.77M.
What is Race Oncology Limited Price to Earnings Ratio (PE Ratio)?
Race Oncology Limited PE Ratio is now.
What was Race Oncology Limited earnings per share over the trailing 12 months (TTM)?
Race Oncology Limited EPS is -0.07 AUD over the trailing 12 months.
Which sector does the Race Oncology Limited company belong to?
The Race Oncology Limited sector is Healthcare.